European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.
AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of its treatment for acute hepatitis C. The final ...
People could learn within 15 minutes whether they are infected with hepatitis C, thanks to a rapid test developed by Northwestern University. The test will allow doctors to diagnose infections during ...
EMA committee recommends approval for AbbVie’s Maviret for the treatment of acute hepatitis C infection: North Chicago, Illinois Monday, May 25, 2026, 18:00 Hrs [IST] AbbVie, an ...
MANCHESTER and LONDON, England — Alison Starkie spends her days tracking down people who need testing or treatment for ...
On Tuesday, Cherokee Nation Principal Chief Chuck Hoskin Jr. signed a proclamation designating May as Hepatitis C Awareness ...
WASHINGTON – It is possible to end the transmission of hepatitis B and C and prevent further sickness and deaths from the diseases, but time, considerable resources, and attention to various barriers ...
Oregon Health & Science University (OHSU) has been awarded $7.5 million in federal funding to increase treatment and ...
Gail Hawthorn is a clinical nurse specialist in hepatitis C liaison ...
The Wisconsin Department of Health Services (DHS) is announcing a plan to eliminate viral hepatitis and a public dashboard to ...